secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-01-12T23:59:59+00:00
Accession:  0001005286-24-000013
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore Biomedical receives Nasdaq notice for delayed quarterly and annual filings
--------------------------------------------------------------------------------

- Nasdaq notified Lifecore on Jan 10, 2024 that it is not compliant with Listing Rule 5250(c)(1) due to delayed Q2 Form 10-Q and continued delays in Form 10-K and Q1 Form 10-Q.
- The company had a previously approved compliance plan with an exception period until Feb 12, 2024 to file Form 10-K and Q1 Form 10-Q.
- Lifecore plans to submit an updated compliance plan by Jan 25, 2024 to address the Q2 Form 10-Q filing and regain compliance.
- The notice has no immediate effect on the listing or trading of LFCR common stock on Nasdaq Global Select Market.
- The company continues to work to complete the filings but cannot assure regaining compliance by the deadline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000013/0001005286-24-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000013/lndc-20240110.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer